Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
February-2016 Volume 13 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2016 Volume 13 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Caveolin‑1 is essential in the differentiation of human adipose‑derived stem cells into hepatocyte‑like cells via an MAPK pathway‑dependent mechanism

  • Authors:
    • Xin Guan
    • Nan Wang
    • Fenggong Cui
    • Yang Liu
    • Peng Liu
    • Jingyuan Zhao
    • Chao Han
    • Xiaoyan Li
    • Zhiqian Leng
    • Ying Li
    • Xiaofei Ji
    • Wei Zou
    • Jing Liu
  • View Affiliations / Copyright

    Affiliations: Regenerative Medicine Centre, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, P.R. China, Liaoning Key Laboratories of Biotechnology and Molecular Drug Research and Development, College of Life Science, Liaoning Normal University, Dalian, Liaoning 116029, P.R. China
    Copyright: © Guan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 1487-1494
    |
    Published online on: December 30, 2015
       https://doi.org/10.3892/mmr.2015.4743
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Human adipose‑derived stem cells (hADSCs), widely present in the adult human body, are an emerging and attractive tool for the establishment of stem cell‑based therapies for the treatment of liver disease. However, the mechanism underlying hADSCs hepatic differentiation remains to be elucidated. Caveolin‑1 (Cav‑1), a 21‑24 kDa membrane structural protein, is important in liver regeneration and development. In the present study, fluorescence immunocytochemistry and western blotting were used to analyze the expression levels of Cav‑1 and evaluate its effects on the hepatic differentiation of hADSCs. The results revealed that primary hADSCs preserved the ability to proliferate and differentiate into hepatocyte‑like cells. As demonstrated by semiquantitative reverse transcription‑polymerase chain reaction, hepatocyte‑inducing factors significantly increased the expression of Cav‑1 in a time‑dependent manner, as indicated by increased expression levels of the albumin (ALB) and α‑fetoprotein (AFP) markers. In addition the expression levels of ALB and HNF1A significantly decreased following small interfering RNA‑mediated knockdown of Cav‑1. The mitogen‑activated protein kinase (MAPK) signaling pathway was activated during hepatic differentiation and inhibited following Cav‑1 knockdown. These results suggested that Cav‑1 may regulate the hepatocyte‑like differentiation of hADSCs by modulating mitogen‑activated protein kinase kinase/MAPK signaling. The results of the present study will provide experimental and theoretical basis for further clinical studies on stem cell transplantation in the treatment of liver disease.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Glanemann M, Gaebelein G, Nussler N, Hao L, Kronbach Z, Shi B, Neuhaus P and Nussler AK: Transplantation of monocyte-derived hepatocyte-like cells (NeoHeps) improves survival in a model of acute liver failure. Ann Surg. 249:149–154. 2009. View Article : Google Scholar

2 

Hossein Aghdaie M, Geramizadeh B, Azarpira N, Esfandiari E, Darai M, Rahsaz M, Nikeghbalian S and Malekhosseini SA: Hepatocyte isolation from unused/rejected livers for transplantation: Initial step toward hepatocyte transplantation, the first experience from iran. Hepat Mon. 13:e103972013.PubMed/NCBI

3 

Forbes SJ and Alison MR: Regenerative medicine: Knocking on the door to successful hepatocyte transplantation. Nat Rev Gastroenterol Hepatol. 11:277–278. 2014. View Article : Google Scholar : PubMed/NCBI

4 

Zheng MH, Ye C, Braddock M and Chen YP: Liver tissue engineering: Promises and prospects of new technology. Cytotherapy. 12:349–360. 2010. View Article : Google Scholar : PubMed/NCBI

5 

Williams AR and Hare JM: Mesenchymal stem cells: Biology, pathophysiology, translational findings and therapeutic implications for cardiac disease. Circ Res. 109:923–940. 2011. View Article : Google Scholar : PubMed/NCBI

6 

Aurich H, Sgodda M, Kaltwasser P, Vetter M, Weise A, Liehr T, Brulport M, Hengstler JG, Dollinger MM, Fleig WE and Christ B: Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut. 58:570–581. 2009. View Article : Google Scholar

7 

Anzalone R, Lo Iacono M, Corrao S, Magno F, Loria T, Cappello F, Zummo G, Farina F and La Rocca G: New emerging potentials for human Wharton's jelly mesenchymal stem cells: Immunological features and hepatocyte-like differentiative capacity. Stem Cells Dev. 19:423–438. 2010. View Article : Google Scholar

8 

Al Battah F, De Kock J, Vanhaecke T and Rogiers V: Current status of human adipose-derived stem cells: Differentiation into hepatocyte-like cells. Scientific World Journal. 11:1568–1581. 2011. View Article : Google Scholar

9 

Zhu Y, Liu T, Song K, Fan X, Ma X and Cui Z: Adipose-derived stem cell: A better stem cell than BMSC. Cell Biochem Funct. 26:664–675. 2008. View Article : Google Scholar : PubMed/NCBI

10 

Huang SJ, Fu RH, Shyu WC, Liu SP, Jong GP, Chiu YW, Wu HS, Tsou YA, Cheng CW and Lin SZ: Adipose-derived stem cells: Isolation, characterization and differentiation potential. Cell Transplant. 22:701–709. 2013. View Article : Google Scholar

11 

Ruiz JC, Ludlow JW, Sherwood S, Yu G, Wu X and Gimble JM: Differentiated human adipose-derived stem cells exhibit hepatogenic capability in vitro and in vivo. J Cell Physiol. 225:429–436. 2010. View Article : Google Scholar : PubMed/NCBI

12 

Zhang X, Shen P, Coleman M, Zou W, Loggie BW, Smith LM and Wang Z: Caveolin-1 down-regulation activates estrogen receptor alpha expression and leads to 17beta-estradiol-stimulated mammary tumorigenesis. Anticancer Res. 25:369–375. 2005.PubMed/NCBI

13 

Wang XX, Wu Z, Huang HF, Han C, Zou W and Liu J: Caveolin-1, through its ability to negatively regulate TLR4, is a crucial determinant of MAPK activation in LPS-challenged mammary epithelial cells. Asian Pac J Cancer Prev. 14:2295–2299. 2013. View Article : Google Scholar : PubMed/NCBI

14 

Frank PG and Lisanti MP: Caveolin-1 and liver regeneration: role in proliferation and lipogenesis. Cell Cycle. 6:115–116. 2007. View Article : Google Scholar : PubMed/NCBI

15 

Fernández-Rojo MA, Gongora M, Fitzsimmons RL, Martel N, Martin SD, Nixon SJ, Brooks AJ, Ikonomopoulou MP, Martin S, Lo HP, et al: Caveolin-1 is necessary for hepatic oxidative lipid metabolism: Evidence for crosstalk between caveolin-1 and bile acid signaling. Cell Rep. 4:238–247. 2013. View Article : Google Scholar : PubMed/NCBI

16 

Salem AF, Bonuccelli G, Bevilacqua G, Arafat H, Pestell RG, Sotgia F and Lisanti MP: Caveolin-1 promotes pancreatic cancer cell differentiation and restores membranous E-cadherin via suppression of the epithelial-mesenchymal transition. Cell Cycle. 10:3692–3700. 2011. View Article : Google Scholar : PubMed/NCBI

17 

Li Y, Luo J, Lau WM, Zheng G, Fu S, Wang TT, Zeng HP, So KF, Chung SK, Tong Y, et al: Caveolin-1 plays a crucial role in inhibiting neuronal differentiation of neural stem/progenitor cells via VEGF signaling-dependent pathway. PLoS One. 6:e229012011. View Article : Google Scholar : PubMed/NCBI

18 

Rossi S, Poliani PL, Cominelli M, Bozzato A, Vescovi R, Monti E and Fanzani A: Caveolin 1 is a marker of poor differentiation in Rhabdomyosarcoma. Eur J Cancer. 47:761–772. 2011. View Article : Google Scholar

19 

Locke M, Windsor J and Dunbar PR: Human adipose-derived stem cells: Isolation, characterization and applications in surgery. ANZ J Surg. 79:235–244. 2009. View Article : Google Scholar : PubMed/NCBI

20 

Bunnell BA, Flaat M, Gagliardi C, Patel B and Ripoll C: Adipose-derived stem cells: Isolation, expansion and differentiation. Methods. 45:115–120. 2008. View Article : Google Scholar : PubMed/NCBI

21 

Gimble JM, Katz AJ and Bunnell BA: Adipose-derived stem cells for regenerative medicine. Circ Res. 100:1249–1260. 2007. View Article : Google Scholar : PubMed/NCBI

22 

Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M, Kawamata M, Kato T, Okochi H and Ochiya T: IFATS collection: In vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells. 26:2705–2712. 2008. View Article : Google Scholar : PubMed/NCBI

23 

Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M, Kato T, Okochi H and Ochiya T: Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. J Gastroenterol Hepatol. 24:70–77. 2009. View Article : Google Scholar

24 

Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Quinn G, Okochi H and Ochiya T: Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology. 46:219–228. 2007. View Article : Google Scholar : PubMed/NCBI

25 

Sgodda M, Aurich H, Kleist S, Aurich I, König S, Dollinger MM, Fleig WE and Christ B: Hepatocyte differentiation of mesenchymal stem cells from rat peritoneal adipose tissue in vitro and in vivo. Exp Cell Res. 313:2875–2886. 2007. View Article : Google Scholar : PubMed/NCBI

26 

Chen X, Zhang S, Liu T, Liu Y and Wang Y: Maintenance of rat hepatocytes under inflammation by coculture with human orbital fat-derived stem cells. Cell Mol Biol Lett. 17:182–195. 2012. View Article : Google Scholar : PubMed/NCBI

27 

Li X, Yuan J, Li W, Liu S, Hua M, Lu X and Zhang H: Direct differentiation of homogeneous human adipose stem cells into functional hepatocytes by mimicking liver embryogenesis. J Cell Physiol. 229:801–812. 2014. View Article : Google Scholar

28 

Mimeault M and Batra SK: Recent progress on tissue-resident adult stem cell biology and their therapeutic implications. Stem Cell Rev. 4:27–49. 2008. View Article : Google Scholar : PubMed/NCBI

29 

Stolzing A, Jones E, McGonagle D and Scutt A: Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies. Mech Ageing Dev. 129:163–173. 2008. View Article : Google Scholar : PubMed/NCBI

30 

Shi YY, Nacamuli RP, Salim A and Longaker MT: The osteogenic potential of adipose-derived mesenchymal cells is maintained with aging. Plast Reconstr Surg. 116:1686–1696. 2005. View Article : Google Scholar : PubMed/NCBI

31 

Mailey B, Hosseini A, Baker J, Young A, Alfonso Z, Hicok K, Wallace AM and Cohen SR: Adipose-derived stem cells: Methods for isolation and applications for clinical use. Methods Mol Biol. 1210:161–181. 2014. View Article : Google Scholar : PubMed/NCBI

32 

Sterodimas A, de Faria J, Nicaretta B and Pitanguy I: Tissue engineering with adipose-derived stem cells (ADSCs): Current and future applications. J Plast Reconstr Aesthet Surg. 63:1886–1892. 2010. View Article : Google Scholar

33 

Ren G, Liu Y, Wang XM, Zhao CH and Zou W: Role of caveolin-1 down-regulation by iRNA in human hepatocyte proliferation. Zhonghua Gan Zang Bing Za Zhi. 16:379–382. 2008.In Chinese. PubMed/NCBI

34 

Fernández MA, Albor C, Ingelmo-Torres M, Nixon SJ, Ferguson C, Kurzchalia T, Tebar F, Enrich C, Parton RG and Pol A: Caveolin-1 is essential for liver regeneration. Science. 313:1628–1632. 2006. View Article : Google Scholar : PubMed/NCBI

35 

Mayoral R, Fernández-Martínez A, Roy R, Boscá L and Martín-Sanz P: Dispensability and dynamics of caveolin-1 during liver regeneration and in isolated hepatic cells. Hepatology. 46:813–822. 2007. View Article : Google Scholar : PubMed/NCBI

36 

Bosch M, Marí M, Herms A, Fernández A, Fajardo A, Kassan A, Giralt A, Colell A, Balgoma D, Barbero E, et al: Caveolin-1 deficiency causes cholesterol-dependent mitochondrial dysfunction and apoptotic susceptibility. Curr Biol. 21:681–686. 2011. View Article : Google Scholar : PubMed/NCBI

37 

Baker N and Tuan RS: The less-often-traveled surface of stem cells: Caveolin-1 and caveolae in stem cells, tissue repair and regeneration. Stem Cell Res Ther. 4:902013. View Article : Google Scholar : PubMed/NCBI

38 

Frank PG, Pavlides S, Cheung MW, Daumer K and Lisanti MP: Role of caveolin-1 in the regulation of lipoprotein metabolism. Am J Physiol Cell Physiol. 295:C242–C248. 2008. View Article : Google Scholar : PubMed/NCBI

39 

Fernández-Rojo MA, Restall C, Ferguson C, Martel N, Martin S, Bosch M, Kassan A, Leong GM, Martin SD, McGee SL, et al: Caveolin-1 orchestrates the balance between glucose and lipid-dependent energy metabolism: Implications for liver regeneration. Hepatology. 55:1574–1584. 2012. View Article : Google Scholar

40 

Campbell JS, Argast GM, Yuen SY, Hayes B and Fausto N: Inactivation of p38 MAPK during liver regeneration. Int J Biochem Cell Biol. 43:180–188. 2011. View Article : Google Scholar :

41 

Liang L, Ma T, Chen W, Hu J, Bai X, Li J and Liang T: Therapeutic potential and related signal pathway of adipose-derived stem cell transplantation for rat liver injury. Hepatol Res. 39:822–832. 2009. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Guan X, Wang N, Cui F, Liu Y, Liu P, Zhao J, Han C, Li X, Leng Z, Li Y, Li Y, et al: Caveolin‑1 is essential in the differentiation of human adipose‑derived stem cells into hepatocyte‑like cells via an MAPK pathway‑dependent mechanism. Mol Med Rep 13: 1487-1494, 2016.
APA
Guan, X., Wang, N., Cui, F., Liu, Y., Liu, P., Zhao, J. ... Liu, J. (2016). Caveolin‑1 is essential in the differentiation of human adipose‑derived stem cells into hepatocyte‑like cells via an MAPK pathway‑dependent mechanism. Molecular Medicine Reports, 13, 1487-1494. https://doi.org/10.3892/mmr.2015.4743
MLA
Guan, X., Wang, N., Cui, F., Liu, Y., Liu, P., Zhao, J., Han, C., Li, X., Leng, Z., Li, Y., Ji, X., Zou, W., Liu, J."Caveolin‑1 is essential in the differentiation of human adipose‑derived stem cells into hepatocyte‑like cells via an MAPK pathway‑dependent mechanism". Molecular Medicine Reports 13.2 (2016): 1487-1494.
Chicago
Guan, X., Wang, N., Cui, F., Liu, Y., Liu, P., Zhao, J., Han, C., Li, X., Leng, Z., Li, Y., Ji, X., Zou, W., Liu, J."Caveolin‑1 is essential in the differentiation of human adipose‑derived stem cells into hepatocyte‑like cells via an MAPK pathway‑dependent mechanism". Molecular Medicine Reports 13, no. 2 (2016): 1487-1494. https://doi.org/10.3892/mmr.2015.4743
Copy and paste a formatted citation
x
Spandidos Publications style
Guan X, Wang N, Cui F, Liu Y, Liu P, Zhao J, Han C, Li X, Leng Z, Li Y, Li Y, et al: Caveolin‑1 is essential in the differentiation of human adipose‑derived stem cells into hepatocyte‑like cells via an MAPK pathway‑dependent mechanism. Mol Med Rep 13: 1487-1494, 2016.
APA
Guan, X., Wang, N., Cui, F., Liu, Y., Liu, P., Zhao, J. ... Liu, J. (2016). Caveolin‑1 is essential in the differentiation of human adipose‑derived stem cells into hepatocyte‑like cells via an MAPK pathway‑dependent mechanism. Molecular Medicine Reports, 13, 1487-1494. https://doi.org/10.3892/mmr.2015.4743
MLA
Guan, X., Wang, N., Cui, F., Liu, Y., Liu, P., Zhao, J., Han, C., Li, X., Leng, Z., Li, Y., Ji, X., Zou, W., Liu, J."Caveolin‑1 is essential in the differentiation of human adipose‑derived stem cells into hepatocyte‑like cells via an MAPK pathway‑dependent mechanism". Molecular Medicine Reports 13.2 (2016): 1487-1494.
Chicago
Guan, X., Wang, N., Cui, F., Liu, Y., Liu, P., Zhao, J., Han, C., Li, X., Leng, Z., Li, Y., Ji, X., Zou, W., Liu, J."Caveolin‑1 is essential in the differentiation of human adipose‑derived stem cells into hepatocyte‑like cells via an MAPK pathway‑dependent mechanism". Molecular Medicine Reports 13, no. 2 (2016): 1487-1494. https://doi.org/10.3892/mmr.2015.4743
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team